期刊文献+

lncRNA-HEIH在肿瘤中的研究进展 被引量:1

Research progress of lncRNA-HEIH in tumor
下载PDF
导出
摘要 长链非编码RNA(Long non-coding RNA,lncRNA)是一类新的非编码RNA,参与多种疾病的生物学进程。lncRNA-HEIH(High expression in hepatocellular carcinoma,HEIH)通过不同机制调节肿瘤增殖、迁移、侵袭、凋亡以及耐药,其表达水平与肿瘤的临床病理特征相关,在肿瘤发生发展中起关键作用。本文简要介绍了lncRNA-HEIH的概念,对其在肝细胞肝癌、肺癌、乳腺癌、结直肠癌、子宫内膜癌等多种恶性肿瘤中的生物学功能和分子机制进行了系统的综述,探讨了lncRNA-HEIH成为潜在的生物标记物和新的肿瘤治疗靶点的前景。 Long non-coding RNAs(lncRNA)are a new class of non-coding RNAs that participate in the biological processes of many diseases.lncRNA-HEIH(High expression in hepatocellular carcinoma,HEIH)regulates tumor proliferation,migration,invasion,apoptosis and drug resistance through different mechanisms.Its expression level is related to the clinicopathological characteristics of tumors and plays a key role in tumor occurrence and development.This article briefly introduces the concept of lncRNA-HEIH,and systematically reviews its biological functions and molecular mechanisms in hepatocellular carcinoma,lung cancer,breast cancer,colorectal cancer,endometrial cancer and other malignant tumors.The prospect of lncRNA-HEIH is considered as a potential biomarker and a new target for cancer treatment.
作者 冯羽昕(综述) 朱春荣(审校) FENG Yuxin;ZHU Chunrong(The First Affiliated Hospital of Soochow University,Suzhou 215006,China)
出处 《实用肿瘤学杂志》 CAS 2021年第1期87-90,共4页 Practical Oncology Journal
关键词 lncRNA lncRNA-HEIH 肿瘤 生物标志物 lncRNA lncRNA-HEIH Tumor Biomarker
  • 相关文献

参考文献8

二级参考文献37

  • 1Jiang-Shan Lian,Lin-Yan Zeng,Jian-Yang Chen,Hong-Yu Jia,Yi-Min Zhang,Dai-Rong Xiang,Liang Yu,Jian-Hua Hu,Ying-Feng Lu,Ling Zheng,Lan-Juan Li,Yi-Da Yang.De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis[J].World Journal of Gastroenterology,2013,19(37):6278-6283. 被引量:36
  • 2Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma [ J ]. Hepatology, 2002,35 ( 3 ) : 519 - 524.
  • 3Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma [ J ]. Lan- eet, 2012,379 ( 9822 ) : 1245 - 1255.
  • 4Dhanasekaran R, Limaye A, Cabrera R. Hepatoeellular carcinoma : current trends in worldwide epidemiology, risk factors, diagnosis,and therapeutics [ J ]. Hepatic Medicine, Evidence and Res, 2012, 4:19 -37.
  • 5Hao K, Luk JM, Lee NP, et al. Predicting prognosis in hepatocellu- lar carcinoma after curative surgery with common clinicopathologic parameters [ J ]. BMC Cancer,2009,9:389.
  • 6Siegel R, Ward E, Brawley O, et al. Cancer statistics ,2011 : the im- pact of eliminating and racial disparities on prema- ture cancer deaths[ J]. Cancer J ,2011,61 (4) :212 - 236.
  • 7Hauptman N, Glavac D. MicroRNAs and long non - coding RNAs : prospects in diagnostics and therapy of cancer [ J ]. Radiol Oncol, 2013,47(4) :311 -318.
  • 8Li G,Zhang H,Wan X,et al. Long noncoding RNA plays a key role in metastasis and prognosis of hepatocellular carcinoma[ J ]. Biomed Res Int ,2014,2014:780521.
  • 9Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expres- sion in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans [ J ]. Hepatology, 2011,54 (5):1679 - 1689.
  • 10Wu C, Morris JR. Genes, genetics, and epigenetics: a correspon- dence [ J ]. Science ,2001,293 (5532) : 1103 - 1105.

共引文献109

同被引文献15

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部